Nagendra Verma | Life Sciences | Best Researcher Award

Published on by CAD Awards

Dr. Nagendra Verma | Life Sciences | Best Researcher Award 

Research specialist| St. Cloud State University | United States

Dr. Nagendra Verma is a highly accomplished biomedical scientist specializing in cellular and molecular biology, molecular oncology, and regenerative medicine, with over a decade of international research experience. His work focuses on the therapeutic and regulatory roles of extracellular vesicles (EVs) and microRNAs in ocular and cancer biology, particularly exploring their applications in corneal wound healing, stem cell regulation, and STAT3-dependent cancer inhibition. Dr. Verma has authored 11 research publications, cited 104 times by 95 documents, achieving an h-index of 7. His research demonstrates a strong command of molecular diagnostics, genomics, and biophysical methodologies, contributing to significant advancements in understanding disease mechanisms and developing novel therapeutic interventions. He has collaborated extensively within interdisciplinary academic and industrial environments, reflecting his ability to integrate scientific innovation with translational potential. As an active member of global scientific societies such as ARVO, RAPS, and AAMI, Dr. Verma also serves as a reviewer and editorial board member for numerous international journals, including Scientific Reports, Cells, and Molecular Vision. His contributions extend beyond research through mentoring students, presenting at international conferences, and earning recognition for excellence in scientific investigation. Dr. Verma’s work continues to bridge molecular insights with therapeutic innovation, emphasizing precision, collaboration, and impactful discovery in biomedical science.

Profiles: Scopus | Orcid

Featured Publications

  • Verma, N., Franchitto, M., Zonfrilli, A., Cialfi, S., Palermo, R., & Talora, C. (2019). DNA damage stress: Cui prodest? International Journal of Molecular Sciences, 20(5), 1073.

  • Verma, N., Khare, D., Poe, A. J., Amador, C., Ghiam, S., Fealy, A., Ebrahimi, S., Shadrokh, O., Song, X.-Y., Santiskulvong, C., et al. (2023). MicroRNA and protein cargos of human limbal epithelial cell-derived exosomes and their regulatory roles in limbal stromal cells of diabetic and non-diabetic corneas. Cells, 12.

  • Verma, N., Arora, S., Singh, A. K., & Kumar, A. (2025). Extracellular vesicle-associated miRNAs in cornea health and disease: Diagnostic potential and therapeutic implications. Targets, 3(32).

  • Verma, N., Arora, S., Singh, A. K., & Ahmed, J. (2025). Unlocking the potential of exosomes (extracellular vesicles): Drug delivery advancements and therapeutics in ocular diseases. RSC Pharmaceutics, 1(97).

  • Verma, N., & Arora, S. (2025). Navigating the global regulatory landscape for exosome-based therapeutics: Challenges, strategies, and future directions. Pharmaceutics, 17(990).

  • Arora, S., & Verma, N. (2024). Advancing organic electronics through the lens of ionic liquids and polymerized ionic liquids: A review. RSC Applied Polymers.

  • Arora, S., & Verma, N. (2024). Exosomal microRNAs as potential biomarkers and therapeutic targets in corneal diseases. Molecular Vision, 30, 92–106.

  • De Blasio, C., Verma, N., Moretti, M., Cialfi, S., Zonfrilli, A., Franchitto, M., Truglio, F., De Smaele, E., Ichijo, H., Naguro, I., Screpanti, I., & Talora, C. (2021). Functional cooperation between ASK1 and p21(Waf1/Cip1) in the balance of cell-cycle arrest, cell death, and tumorigenesis of stressed keratinocytes. Cell Death Discovery, 7(1), 75.

  • De Blasio, C., Zonfrilli, A., Franchitto, M., Mariano, G., Cialfi, S., Verma, N., Checquolo, S., Bellavia, D., Palermo, R., Benelli, D., Screpanti, I., & Talora, C. (2019). PLK1 targets NOTCH1 during DNA damage and mitotic progression. Journal of Biological Chemistry, 294(47), 17941–17950.

  • Yue, P., Zhu, Y., Brotherton-Pleiss, C., Fu, W., Verma, N., Chen, J., Nakamura, K., Chen, W., Chen, Y., Alonso-Valenteen, F., Mikhael, S., Medina-Kauwe, L., Kershaw, K. M., Celeridad, M., Pan, S., Limpert, A. S., Sheffler, D. J., Cosford, N. D. P., Shiao, S. L., & Turkson, J. (2022). Novel potent azetidine-based compounds irreversibly inhibit STAT3 activation and induce antitumor response against human breast tumor growth in vivo. Cancer Letters, 534, 215613.

 

 

 

Sharmin Sultana | Life Science | Best Researcher Award

Published on by CAD Awards

Ms. Sharmin Sultana | Life Science | Best Researcher Award

PhD Student | Nicolaus Copernicus University in Torun | Poland

Sharmin Sultana is a dynamic researcher specializing in molecular biology, bioinformatics, and translational biotechnology, with a focus on integrating wet-lab and computational approaches for genomic, transcriptomic, and proteomic investigations. Her research primarily explores hepatoprotective molecular mechanisms of medicinal herb extracts against aflatoxin B1-induced liver toxicity using both in-vivo and in-vitro models. She has expertise in high-throughput sequencing, small RNA library preparation, miRNA and mRNA data analysis, and functional genomics, employing advanced R/Bioconductor pipelines for differential expression, target prediction, and enrichment analyses. Her recent contributions include studies on microRNA modules in liver transcriptomes, aflatoxin detection and mitigation strategies, and SARS-CoV-2 variant diagnostics using liquid array technology. Sharmin has presented her work at several international conferences in Poland, Germany, and Spain, earning recognition for excellence in research presentation. Her interdisciplinary collaborations span molecular biology, animal biotechnology, and computational genomics, contributing to projects funded under international research consortia. She is proficient in tools such as Cytoscape, MEGA, CLC Genomics Workbench, and BLAST, and skilled in CRISPR-Cas9 genome editing and primary hepatocyte culture. Sharmin’s growing publication record in high-impact journals and conference proceedings reflects her commitment to advancing molecular diagnostics, toxicogenomics, and bioinformatics-driven therapeutic development, bridging experimental and computational biology toward innovative biomedical solutions.

Profiles:  Orcid | Google Scholar

Featured Publications

Kępka-Borkowska, K., Chałaśkiewicz, K., Ogłuszka, M., Borkowski, M., Lepczyński, A., Pareek, C. S., Starzyński, R. R., Lichwiarska, E., Sultana, S., Kalra, G., Purohit, N., Gralak, B., Poławska, E., & Pierzchała, M. (2025). Current approaches to aflatoxin B1 control in food and feed safety: Detection, inhibition, and mitigation. International Journal of Molecular Sciences, 26(13), 6534.

Chałaśkiewicz, K., Kępka-Borkowska, K., Starzyński, R. R., Ogłuszka, M., Borkowski, M., Pierzchała, M., Lepczyński, A., Sultana, S., Kalra, G., Purohit, N., Pareek, C. S., & Poławska, E. (2025). Impact of aflatoxins on the digestive, immune, and nervous systems: The role of microbiota and probiotics in toxicity protection. International Journal of Molecular Sciences, 26(17), 8258.

Sharma, P., Asediya, V., Kalra, G., Sultana, S., Purohit, N., Kibitlewska, K., Pareek, C. S., & Wimmers, K. (2025). Hepatoprotective effect of silymarin herb in prevention of liver dysfunction using pig as animal model. Nutrients, 17(20), 3278.

Pareek, C. S., Sachajko, M., Kalra, G., Sultana, S., Szostak, A., Chałaśkiewicz, K., Kępka-Borkowska, K., Poławska, E., Ogłuszka, M., Pierzchała, M., Starzyński, R. R., Taniguchi, H., Juszczuk-Kubiak, E., Lepczyński, A., Ślaska, B., Kozera, W., Czarnik, U., Kadarmideen, H. N., Te Pas, M. F. W., … Szyda, J. (2025). Identification of trait-associated microRNA modules in liver transcriptome of pig fed with PUFAs-enriched supplementary diet. Journal of Applied Genetics, 66(2), 389–407.

Sultana, S. (2024). Liquid array diagnostics technology for SARS-CoV-2 variant detection. Inland Norway University of Applied Sciences.

Haruto Nishida | Medicine| Best Researcher Award

Published on by CAD Awards

Assoc. Prof. Dr.Haruto Nishida| Medicine |Best Researcher Award

Assoc. Prof. Dr. Haruto Nishida  Faculty of MedicineOita University,Japan.

Dr. Haruto Nishida is an Associate Professor in the Department of Diagnostic Pathology at the Faculty of Medicine, Oita University, Japan. He earned his medical degree from Oita University School of Medicine and subsequently obtained a Ph.D. in Diagnostic Pathology from Oita University Graduate School of Medicine.Dr. Nishida began his academic career at Oita University as an Assistant Professor in 2012 and was promoted to Lecturer in 2019.As a general pathologist, he specializes in diagnosing a wide range of organs, including the skin, stomach, lungs, uterine cervix, and brain. He has a particular interest in dermatopathology and regularly presents his research at international conferences such as the American Society of Dermatopathology (ASDP) and the United States and Canadian Academy of Pathology (USCAP)

Publication Profile

Orcid

Scopus

Education :

Dr. Haruto Nishida obtained his Medical Degree from the Faculty of Medicine, Oita University, Japan, in 2009. He later pursued a Doctor of Philosophy (PhD) at the Graduate School of Medicine, Oita University, completing his doctoral studies in 2015.

Experience :

Dr. Nishida has an extensive background in diagnostic pathology and has held various academic and clinical positions:Resident in General Medicine, Oita Medical Hospital, Yufu, Japan (2009–2011)Fellow in Diagnostic Pathology, Oita University, Japan (2011–2012)Assistant Professor, Department of Diagnostic Pathology, Oita University (2012–2019)Lecturer, Department of Diagnostic Pathology, Oita University (2019–2020)Associate Professor, Department of Diagnostic Pathology, Oita University (2020–Present)Clinical Fellow, various international institutions including Centre Léon Bérard, France; St John’s Institute of Dermatology, UK; Universitätsklinikum Münster, Germany; and Medical University of South Carolina, USA (2024–Present)

Research Focus :

Dr. Nishida’s research interests include:Dermatopathology and Molecular PathologySoft Tissue and Bone TumorsCytopathology and Autopsy PathologyMolecular Mechanisms in Skin and Gynecologic PathologiesDiagnostic and Digital Pathology InnovationsHis research has contributed significantly to understanding various pathological conditions, including rare tumors and molecular alterations in dermatological diseases.

 

Awards:

Dr. Nishida has been recognized for his contributions to pathology, including:Outstanding Researcher Award by the Japanese Society of PathologyBest Paper Award for his contributions to dermatopathology researchAcademic Excellence Award from Oita UniversityYoung Investigator Award in Molecular Pathology

Publication :

A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan

The relationship between tumor immunity and the cGAS–STING pathway in breast cancer: An immunohistochemical study

 Conclusion

Dr. Nishida is highly suitable for the award, particularly in the field of diagnostic pathology and molecular pathology. If the award criteria prioritize international recognition, impact factor, and leadership, he stands as a strong contender but could further improve his research influence globally

 

Jacek KUBIAK | Stem cell biotechnology | Excellence in Research

Published on by CAD Awards

Jacek KUBIAK | Stem cell biotechnology | Excellence in Research 

Jacek KUBIAK , National Centre for Scientific Research , France 

Jacek Kubiak, with a profound academic and research background, has significantly contributed to the field of molecular biology, embryology, cell cycle regulation, and regenerative medicine. His extensive experience, impactful publications, leadership roles, and dedication to scientific research and education demonstrate his eligibility for an Excellence in Research Award.

 

Professional Profiles:

scopus

orcid 

Education :

Jacek Kubiak holds a Ph.D. from the University of Warsaw, where he conducted pioneering research on mouse oocyte activation and pronuclei formation. He further advanced his expertise with a habilitation to direct research (HDR) from the University of Rennes 1. His academic journey is marked by substantial training and research experiences across prominent institutions, including the University of Wisconsin, Madison, Marine Biological Laboratory, Woods Hole, and various European laboratories.

Experience:

Throughout his career, Kubiak has held influential positions such as a CNRS researcher and Director of Research in France, and an Assistant Professor in Poland. He has directed several research groups, including the “Mitosis and Meiosis” team and the Laboratory of Regenerative Medicine and Cell Biology. His leadership extended to administrative roles, participating in scientific committees and commissions at the University of Rennes 1 and the CNRS.

Skills:

Jacek Kubiak’s skills encompass a wide range of expertise in molecular biology, embryology, cell cycle regulation, and regenerative medicine. He is proficient in the study of molecular mechanisms of early embryo development, which includes the intricate processes of cell division and differentiation. His skills in cell cycle regulation are evidenced by his work on mitosis and meiosis, essential for understanding how cells replicate and divide accurately. Kubiak is adept in stem cell research, focusing on the potential of these cells in regenerative medicine and their application in treating various medical conditions. His research on the role of macrophages in innate immune response demonstrates his capability in immunology, particularly in understanding how the body defends itself against pathogens. Furthermore, his experience in directing research groups and laboratories showcases his leadership and project management skills. Kubiak is also proficient in mentoring and supervising students and postdoctoral researchers, highlighting his commitment to education and knowledge dissemination. His editorial activities and conference organization skills underscore his ability to contribute to and shape the scientific community. Overall, Jacek Kubiak’s skills reflect his comprehensive and profound expertise in biological research, education, and leadership.

Research Focus:

Jacek Kubiak’s research focus is deeply rooted in understanding the molecular mechanisms underlying early embryo development and cell cycle regulation. His studies delve into the intricacies of how cells divide and differentiate, particularly through the processes of mitosis and meiosis. Kubiak has made significant contributions to the field of stem cell research, exploring their potential in regenerative medicine and their applications in medical treatments. He is also focused on the role of macrophages in the innate immune response, investigating how these cells contribute to the body’s defense mechanisms against infections. Additionally, his recent work has included coordinating an international research group focused on understanding SARS-CoV-2 infection in pediatric patients, reflecting his ability to adapt his research to current global health challenges. Kubiak’s extensive research has resulted in over 170 highly cited scientific papers, demonstrating his influence and contributions to the fields of developmental biology, molecular biology, and regenerative medicine. His interdisciplinary approach combines fundamental biological research with practical medical applications, aiming to translate scientific discoveries into therapeutic solutions.

Conclusion:

Jacek Kubiak’s remarkable career, marked by distinguished research, leadership, mentorship, and editorial contributions, underscores his suitability for an Excellence in Research Award. His dedication to understanding complex biological processes and applying this knowledge to medical advancements, particularly in regenerative medicine and infectious diseases, exemplifies his exceptional contribution to science. Therefore, recognizing his achievements with an Excellence in Research Award would honor his significant impact on the scientific community.

Publications :

    1. Adipose-derived mesenchymal stem cells’ adipogenesis chemistry analyzed by FTIR and Raman metrics
      • Authors: Augustyniak, K., Lesniak, M., Latka, H., … Zdanowski, R., Malek, K.
      • Journal: Journal of Lipid Research, 2024, 65(7)
      • 🧬🧪📊
    2. Gadolinium retention effect on macrophages — a potential cause of MRI contrast agent Dotarem toxicity
      • Authors: Halasa, M., Uosef, A., Ubelaker, H.V., … Wosik, J., Kloc, M.
      • Journal: Cell and Tissue Research, 2024, 397(1), pp. 51–60
      • ⚛️🩺🔬
    3. How the Timing of Biological Processes Is Controlled and Modified at the Molecular and Cellular Level? 2.0
      • Authors: Kubiak, J.Z., Kloc, M.
      • Journal: Biology, 2024, 13(3), 170
      • ⏳🔬🧫
    4. Invertebrate Immunity, Natural Transplantation Immunity, Somatic and Germ Cell Parasitism, and Transposon Defense
      • Authors: Kloc, M., Halasa, M., Kubiak, J.Z., Ghobrial, R.M.
      • Journal: International Journal of Molecular Sciences, 2024, 25(2), 1072
      • 🦀🦠🛡️
    5. The Role of Human and Animal Monocytes and Macrophages in Homeostasis and Disease
      • Authors: Kloc, M., Kubiak, J.Z.
      • Journal: International Journal of Molecular Sciences, 2023, 24(22), 16397
      • 🧬🐾🔬
    6. Why Do We Study Aquatic Organisms?
      • Authors: Kloc, M., Kubiak, J.Z.
      • Journal: International Journal of Molecular Sciences, 2023, 24(21), 15807
      • 🌊🦑🔬
    7. Coronavirus Disease Pathophysiology: Biomarkers, Potential New Remedies, Comorbidities, Long COVID-19, Post Pandemic Epidemiological Surveillance
      • Authors: Kubiak, J.Z., Kloc, M.
      • Journal: International Journal of Molecular Sciences, 2023, 24(15), 12236
      • 🦠🧬🌡️
    8. CDC6 as a Key Inhibitory Regulator of CDK1 Activation Dynamics and the Timing of Mitotic Entry and Progression
      • Authors: El Dika, M., Dudka, D., Kloc, M., Kubiak, J.Z.
      • Journal: Biology, 2023, 12(6), 855
      • ⏱️🔬🧪